Biomarkers in Cancer Therapy

Ben Weintraub Ph.D. hosts this discussion with Dr. Antonio Jimeno. Dr. Jimeno is an assistant professor of Oncology and the Director of Developmental Therapeutics and Pharmacodynamic Laboratory at the University of Colorado Cancer Center. One of the biggest unknowns in oncology is how quickly we will be able to make better choices about the use of targeted cancer agents using predictive biomarkers. Therefore, the topic of today’s call is the state-of-the-art biomarkers in cancer therapy. You can hear the opening few minutes of this call. If you would like to join or start a discussion on this topic please join us at http://inthought.ning.com/.